Want to join the conversation?
$ENDP's revenue from U.S. Branded Pharmaceuticals for 4Q15 jumped 54% to $379MM from last year, on strategic addition of Auxilium Pharma. Sales of Voltaren Gel increased 24% on higher volumes resulting from increased sales and marketing efforts. Sales of Lidoderm rose 1% on net price gains and lower return reserves.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?